Concept Group of Companies

Candesartan

• Category :

  Pharmaceuticals and Biochemicals/Others

• Synonyms :

  2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]-3H-benzoimidazole-4-carboxylic acid;1H-Benzimidazole-7-carboxylic acid;2-ethoxy-1-((2'-(1H-tetrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-;2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxy lic acid;2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benz imidazole-7-carboxylic acid;Blopress;Blopress (TN);C07468;Candesartan (USAN);Candesartan [USAN:INN];CHEBI:3347;CV 11974;D00522;1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate;2-ethoxy-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid;(4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;

• CAS NO :

  139481-59-7

• EC NO :

• Molecular Formula :

  C₂₄H₂₀N₆O₃

• Molecular Weight :

  440.45

• Main Specifications :

• InChI :

  InChI:1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)

• Molecular Structure :